Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Determining the incidence of familiality in ALS: A study of temporal trends in Ireland from 1994 to 2016.

Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A, Pender N, McLaughlin R, Hardiman O.

Neurol Genet. 2018 May 18;4(3):e239. doi: 10.1212/NXG.0000000000000239. eCollection 2018 Jun.

2.

The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.

Pinto-Grau M, Hardiman O, Pender N.

Neuropsychol Rev. 2018 Jun;28(2):251-268. doi: 10.1007/s11065-018-9375-7. Epub 2018 Apr 28. Review.

PMID:
29705950
3.

Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study.

Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O.

Brain Imaging Behav. 2018 Feb 8. doi: 10.1007/s11682-018-9837-9. [Epub ahead of print]

PMID:
29423814
4.

Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.

Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K, Staines A, Galvin M, Pender N.

J Neurol. 2018 Apr;265(4):793-808. doi: 10.1007/s00415-018-8770-6. Epub 2018 Feb 2.

PMID:
29396678
5.

Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis.

Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O.

BMJ Open. 2018 Jan 27;8(1):e018721. doi: 10.1136/bmjopen-2017-018721.

6.

Managing cognitive impairment following stroke: protocol for a systematic review of non-randomised controlled studies of psychological interventions.

Merriman NA, Sexton E, Donnelly NA, McCabe G, Walsh ME, Rohde D, Gorman A, Jeffares I, Pender N, Williams D, Horgan F, Doyle F, Wren MA, Bennett KE, Hickey A.

BMJ Open. 2018 Jan 10;8(1):e019001. doi: 10.1136/bmjopen-2017-019001.

7.

Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, Costello E, Pinto-Grau M, Vajda A, Heverin M, Pender N, Al-Chalabi A, Hardiman O, Abrahams S.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):65-73. doi: 10.1080/21678421.2017.1407794. Epub 2017 Dec 7.

PMID:
29214872
8.

Characteristic Increases in EEG Connectivity Correlate With Changes of Structural MRI in Amyotrophic Lateral Sclerosis.

Nasseroleslami B, Dukic S, Broderick M, Mohr K, Schuster C, Gavin B, McLaughlin R, Heverin M, Vajda A, Iyer PM, Pender N, Bede P, Lalor EC, Hardiman O.

Cereb Cortex. 2017 Nov 9:1-15. doi: 10.1093/cercor/bhx301. [Epub ahead of print]

PMID:
29136131
9.

Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.

O'Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, Byrne S, Pinto-Grau M, Elamin M, Pender N, Hardiman O.

JAMA Neurol. 2017 Dec 1;74(12):1425-1430. doi: 10.1001/jamaneurol.2017.2699.

PMID:
29049464
10.

Mismatch Negativity as an Indicator of Cognitive Sub-Domain Dysfunction in Amyotrophic Lateral Sclerosis.

Iyer PM, Mohr K, Broderick M, Gavin B, Burke T, Bede P, Pinto-Grau M, Pender NP, McLaughlin R, Vajda A, Heverin M, Lalor EC, Hardiman O, Nasseroleslami B.

Front Neurol. 2017 Aug 15;8:395. doi: 10.3389/fneur.2017.00395. eCollection 2017.

11.

Assessing behavioural changes in ALS: cross-validation of ALS-specific measures.

Pinto-Grau M, Costello E, O'Connor S, Elamin M, Burke T, Heverin M, Pender N, Hardiman O.

J Neurol. 2017 Jul;264(7):1397-1401. doi: 10.1007/s00415-017-8536-6. Epub 2017 Jun 9.

PMID:
28600595
12.

Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.

Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, Pender N, Hardiman O, Bede P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):611-623. doi: 10.1080/21678421.2017.1332077. Epub 2017 May 31.

PMID:
28562080
13.

A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival.

Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, Hardiman O.

Ann Clin Transl Neurol. 2017 Apr 11;4(5):305-317. doi: 10.1002/acn3.407. eCollection 2017 May.

14.

Becoming comfortable with "my" epilepsy: Strategies that patients use in the journey from diagnosis to acceptance and disclosure.

Pembroke S, Higgins A, Pender N, Elliott N.

Epilepsy Behav. 2017 May;70(Pt A):217-223. doi: 10.1016/j.yebeh.2017.02.001. Epub 2017 Apr 20.

PMID:
28437750
15.

Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival.

Burke T, Galvin M, Pinto-Grau M, Lonergan K, Madden C, Mays I, Carney S, Hardiman O, Pender N.

J Neurol. 2017 May;264(5):898-904. doi: 10.1007/s00415-017-8448-5. Epub 2017 Mar 9.

PMID:
28280986
16.

Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance.

Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):193-201. doi: 10.1080/21678421.2016.1272615. Epub 2017 Jan 13.

PMID:
28084080
17.

Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):99-106. doi: 10.1080/21678421.2016.1249887. Epub 2016 Nov 28.

PMID:
27894201
18.

Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI).

Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):68-73. doi: 10.1080/21678421.2016.1248976. Epub 2016 Nov 28.

PMID:
27894191
19.

Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.

Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N.

PLoS One. 2016 Aug 24;11(8):e0160850. doi: 10.1371/journal.pone.0160850. eCollection 2016.

20.

Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis.

Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):467-472. Epub 2016 May 6.

PMID:
27152765
21.

Erratum to: Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors.

Burke T, Elamin M, Galvin M, Gallagher L, Hardiman O, Pender N.

J Neurol. 2015 Dec;262(12):2799. doi: 10.1007/s00415-015-7941-y. No abstract available.

PMID:
26566911
22.

Closing the tau loop: the missing tau mutation.

McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, Spillantini MG, Rowland LP, Fahn S, Craig P, Hutton M, Lynch T.

Brain. 2015 Oct;138(Pt 10):3100-9. doi: 10.1093/brain/awv234. Epub 2015 Aug 21.

23.

Functional Connectivity Changes in Resting-State EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis.

Iyer PM, Egan C, Pinto-Grau M, Burke T, Elamin M, Nasseroleslami B, Pender N, Lalor EC, Hardiman O.

PLoS One. 2015 Jun 19;10(6):e0128682. doi: 10.1371/journal.pone.0128682. eCollection 2015.

24.

Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors.

Burke T, Elamin M, Galvin M, Hardiman O, Pender N.

J Neurol. 2015 Jun;262(6):1526-32. doi: 10.1007/s00415-015-7746-z. Epub 2015 Apr 23. Erratum in: J Neurol. 2015 Dec;262(12):2799.

PMID:
25904206
25.

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm.

Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O.

J Neurol. 2015 Jun;262(6):1447-54. doi: 10.1007/s00415-015-7731-6. Epub 2015 Apr 11.

26.

Evaluation of the co-existence of the red fluorescent plaque bacteria P. gingivalis with S. gordonii and S. mutans in white spot lesion formation during orthodontic treatment.

Sadeq A, Risk JM, Pender N, Higham SM, Valappil SP.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):232-7. doi: 10.1016/j.pdpdt.2015.03.001. Epub 2015 Mar 23.

PMID:
25813147
27.

The economic cost of nonepileptic attack disorder in Ireland.

Magee JA, Burke T, Delanty N, Pender N, Fortune GM.

Epilepsy Behav. 2014 Apr;33:45-8. doi: 10.1016/j.yebeh.2014.02.010. Epub 2014 Mar 13.

PMID:
24632352
28.

Basal ganglia involvement in amyotrophic lateral sclerosis.

Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Pender N, Bradley DG, Hardiman O.

Neurology. 2013 Dec 10;81(24):2107-15. doi: 10.1212/01.wnl.0000437313.80913.2c. Epub 2013 Nov 8.

PMID:
24212388
29.

The effects of immunologic brainstem encephalopathy on cognitive function following awakening from a progressive autoimmune coma.

Salomone S, Robertson IH, Lynch T, Balsters JH, Fearon C, Marnane M, Pender NP, Dockree PM.

Neurocase. 2014;20(5):569-80. doi: 10.1080/13554794.2013.826688. Epub 2013 Sep 2.

PMID:
23998396
30.

Multiparametric MRI study of ALS stratified for the C9orf72 genotype.

Bede P, Bokde AL, Byrne S, Elamin M, McLaughlin RL, Kenna K, Fagan AJ, Pender N, Bradley DG, Hardiman O.

Neurology. 2013 Jul 23;81(4):361-9. doi: 10.1212/WNL.0b013e31829c5eee. Epub 2013 Jun 14.

31.

Influence of pubertal stage on local sweating patterns of girls exercising in the heat.

Wilk B, Pender N, Volterman K, Bar-Or O, Timmons BW.

Pediatr Exerc Sci. 2013 May;25(2):212-20.

PMID:
23749395
32.

Insights into thermoregulation: a clinico-radiological description of Shapiro syndrome.

Pazderska A, O'Connell M, Pender N, Gavin C, Murray B, O'Dowd S.

J Neurol Sci. 2013 Jun 15;329(1-2):66-8. doi: 10.1016/j.jns.2013.03.014. Epub 2013 Apr 8.

PMID:
23578790
33.

Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O'Brien C, Phukan J, Lynch C, Pender N, Hardiman O.

Neurology. 2013 Apr 23;80(17):1590-7. doi: 10.1212/WNL.0b013e31828f18ac. Epub 2013 Apr 3.

PMID:
23553481
34.

Metacognitive and online error awareness deficits after prefrontal cortex lesions.

Hoerold D, Pender NP, Robertson IH.

Neuropsychologia. 2013 Feb;51(3):385-91. doi: 10.1016/j.neuropsychologia.2012.11.019. Epub 2012 Nov 27.

PMID:
23196146
35.

Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.

Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O.

J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):766-73. doi: 10.1136/jnnp-2012-302674. Epub 2012 Oct 20.

PMID:
23085933
36.

Social cognition in neurodegenerative disorders: a systematic review.

Elamin M, Pender N, Hardiman O, Abrahams S.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1071-9. doi: 10.1136/jnnp-2012-302817. Epub 2012 Aug 6. Review.

PMID:
22869923
37.

C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism.

O'Dowd S, Curtin D, Waite AJ, Roberts K, Pender N, Reid V, O'Connell M, Williams NM, Morris HR, Traynor BJ, Lynch T.

Mov Disord. 2012 Jul;27(8):1072-4. doi: 10.1002/mds.25022. No abstract available.

38.

Relationship between reaction time, fine motor control, and visual-spatial perception on vigilance and visual-motor tasks in 22q11.2 Deletion Syndrome.

Howley SA, Prasad SE, Pender NP, Murphy KC.

Res Dev Disabil. 2012 Sep-Oct;33(5):1495-502. doi: 10.1016/j.ridd.2012.03.023. Epub 2012 Apr 21.

PMID:
22522207
39.

A comparison of propofol and amobarbital for use in the Wada test.

Magee JA, Pender NP, Abrahams S, Thornton J, Delanty N, Fortune GM.

Seizure. 2012 Jun;21(5):399-401. doi: 10.1016/j.seizure.2012.02.001. Epub 2012 Mar 15.

40.

Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.

Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, Al-Chalabi A, Hardiman O.

Lancet Neurol. 2012 Mar;11(3):232-40. doi: 10.1016/S1474-4422(12)70014-5. Epub 2012 Feb 3. Erratum in: Lancet Neurol. 2012 May;11(5):388.

41.

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study.

Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):102-8. doi: 10.1136/jnnp-2011-300188. Epub 2011 Aug 11.

PMID:
21836033
42.

The contribution of retrospective memory, attention and executive functions to the prospective and retrospective components of prospective memory following TBI.

Clune-Ryberg M, Blanco-Campal A, Carton S, Pender N, O'Brien D, Phillips J, Delargy M, Burke T.

Brain Inj. 2011;25(9):819-31. doi: 10.3109/02699052.2011.589790. Epub 2011 Jul 1.

PMID:
21721845
43.

Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.

Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, Hardiman O.

Neurology. 2011 Apr 5;76(14):1263-9. doi: 10.1212/WNL.0b013e318214359f.

PMID:
21464431
44.

Factors affecting demineralization during orthodontic treatment: a post-hoc analysis of RCT recruits.

Al Maaitah EF, Adeyemi AA, Higham SM, Pender N, Harrison JE.

Am J Orthod Dentofacial Orthop. 2011 Feb;139(2):181-91. doi: 10.1016/j.ajodo.2009.08.028.

PMID:
21300246
45.

Clinician Counseling to Promote Physical Activity [Internet].

Eden KB, Orleans T, Mulrow CD, Pender NJ, Teutsch SM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Aug.

46.

Counseling to Promote a Healthy Diet [Internet].

Ammerman A, Pignone M, Fernandez L, Lohr K, Jacobs AD, Nester C, Orleans T, Pender N, Woolf S, Sutton SF, Lux LJ, Whitener L.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Apr.

47.

The Irish epilepsy surgery experience: Long-term follow-up.

Dunlea O, Doherty CP, Farrell M, Fitzsimons M, O'Brien D, Murphy K, MacMackin D, Pender N, Staunton H, Phillips J, Delanty N.

Seizure. 2010 May;19(4):247-52. doi: 10.1016/j.seizure.2010.03.001. Epub 2010 Mar 31.

48.

Huntington's disease presenting as amyotrophic lateral sclerosis.

Phukan J, Ali E, Pender NP, Molloy F, Hennessy M, Walsh RJ, Hardiman O.

Amyotroph Lateral Scler. 2010 Aug;11(4):405-7. doi: 10.1080/17482960903055958.

PMID:
19530012
49.

The evaluation of a novel method comparing quantitative light-induced fluorescence (QLF) with spectrophotometry to assess staining and bleaching of teeth.

Adeyemi AA, Jarad FD, de Josselin de Jong E, Pender N, Higham SM.

Clin Oral Investig. 2010 Feb;14(1):19-25. doi: 10.1007/s00784-009-0261-9. Epub 2009 Mar 21.

PMID:
19306025
50.

Validation of enamel erosion in vitro.

Elton V, Cooper L, Higham SM, Pender N.

J Dent. 2009 May;37(5):336-41. doi: 10.1016/j.jdent.2009.01.006. Epub 2009 Feb 23.

PMID:
19237234

Supplemental Content

Loading ...
Support Center